| |
|
|
|
Diamedica Therapeutics Inc  
|
|
8.05 -0.37 (-0.04%) |
01-27 16:00 |
|
Open: |
8.3 |
Pre close: |
8.42 |
Target:
|
11.12 
|
|
High: |
8.47 |
Low: |
7.95 |
Resistance:
|
9.52
10.88
|
|
Volume: |
234,412 |
Market Cap: |
151M |
Support:
|
7.32
6.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.69
 |
MACD |
MACD(12,26):
|
0.27 |
|
MA(20): |
9.48 |
Signal(12,26,9): |
0.60 |
|
MA(100): |
5.91 |
Stochastic Oscillator |
%K(14,3):
|
14.64 |
|
MA(250): |
5.20 |
%D(3): |
17.26 |
|
Average Volume(K) |
3-Month: |
22868
|
52-Week |
High:
|
10.88 |
|
10-Days: |
20046 |
Low: |
1.87 |
|
RSI |
RSI(14):
|
43.09 |
Change(%): |
93.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.760 |
Return on Equity (ttm) |
-53.6 |
Shares Out. (M) |
18.74 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-36.9 |
Shares Float (M) |
16.37 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.72 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
39.31 |
|
Forward EPS |
-0.740 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
40 |
|
Book Value (p.s.) |
1.590 |
EBITDA (p.s.) |
-0.666 |
P/E |
-10.59 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.03 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.25 |
P/CF |
-18.79 |
|
|
|
|
|
|
